US 7153514
Use of botulinum toxin therapy for prostatic hyperplasia and related disorders
granted A61KA61K31/165A61K31/529
Quick answer
US patent 7153514 (Use of botulinum toxin therapy for prostatic hyperplasia and related disorders) held by The Regents of the University of Colorado expires Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado
- Grant date
- Tue Dec 26 2006 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 21 2026 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K31/165, A61K31/529, A61K38/1703, A61K38/4893